Loading clinical trials...

UNKNOWNNA

Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction

Single-Blinded Randomized Controlled Trial: Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction

NCT06181838•Indonesia University

View on ClinicalTrials.gov

Summary

This study will compare the quality of life between 2 groups, which are group that receive standard moderate acne therapy in addition of lesion extractions, and the second group which only receive standard moderate acne therapy without lesion extractions.

Detailed Description

The group allocation will be randomized. Outcome of the study is the quality of life score based on Acne-QoL-INA questionnaire. The study duration is 8 weeks, consists of baseline visit and 2 follow ups at 4th and 8th weeks.

Eligibility

Age

18 - 59 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Clinically diagnosed as moderate acne vulgaris
•Able to read and speak in Indonesia
•Indonesian Citizen
•Sign the consent form

Exclusion Criteria

•Pregnant of breastfeeding women
•Acne vulgaris lesion located only outside of face
•Experiencing COVID-19 symptoms
•Using retinoid acid containing cream or benzoil peroxide in the last 2 weeks
•Consume any oral antibiotics in the last 1 month
•Injected with intralesional steroid or having acne lesions extracted in the last 2 weeks
•Having laser or chemical peeling in the last 1 month

Locations (1)

Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo

Jakarta Pusat, DKI Jakarta, Indonesia

Key Dates

Start Date

August 28, 2023

Primary Completion Date

November 24, 2023

Completion Date

January 3, 2024

Last Updated

December 29, 2023

Enrollment

ACTUAL participants

Conditions

Acne VulgarisQuality of Life

Interventions

Lesion extraction

PROCEDURE

Tretinoin

DRUG

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07444697

Erectile DisfunctionCoronary Artery Disease (CAD)+3 more

View study

RECRUITINGPHASE3

PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury

NCT06819592

All-cause MortalityQuality of Life+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 29, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction

Inclusion Criteria

Exclusion Criteria

"Erectile Function After PCI in MI and Non-MI Patients"

PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury

Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer Diagnosis Taken to Curative Resectable Surgery

The PREGNANT (Pregnant Resident Empowerment, GuidaNce, and Advocacy iN Training) Coaching Project

Improving Congenital Heart Disease Care

Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris